News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immutep.
RELATED STOCKHEAD STORIES
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
Health & Biotech
Immutep partners with LabCorp to develop immotherapy diagnostic
Health & Biotech
Czech hospital begins COVID study testing Immutep’s efti drug
News
Last Orders: What you might have missed today on the ASX
Experts
ScoPo’s Health Powerplays: The money keeps flowing for the ASX biotechs
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s dodging bullets today?
Health & Biotech
Immutep’s cancer-fighting drug candidate efti shows early promise
News
10 at 10: These ASX stocks have imposed their presence this morning
Health & Biotech
Aged care operator Estia falls to loss as COVID-19 costs bite
Health & Biotech
Health: Immutep has dosed the last patient in one of its cancer studies
Health & Biotech
Selvax cures cancer in dogs, says it’s eyeing an IPO
Health & Biotech
ATO blocks biotech access to Jobkeeper wage subsidy
Health & Biotech
Check up: COVID-19 still sells but investors are looking for the next endorphin hit
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Pharmaxis forges ahead with phase 2 cancer drug trial in spite of COVID-19
Health & Biotech
